1.Study on pharmacological effects and mechanism of Naozhifu as a new drug candidate for prevention and treatment of Alzheimer′s disease base on multiple targets strategy
Chongqing Medicine 2016;45(10):1313-1315,1319
Objective To evaluate the effect of Naozhifu as a multifunctional agents for the prevention and treatment of Alzheimer’s disease(AD) .Methods On 30th after castration ,female mice were received intrahippocampal injection of Aβ1‐42 and ibotenic acid for replicating the AD model .On the next day ,these modeled mice were randomly divided into model group ,low dose of Naazhifu group ,middle dose of Naozhifu group ,high dose of Naozhifu group and piracetam group ,sham operated mice were set as control group .Then the gavage was given once a day for 4 consecutive weeks .Furthermore the step‐down passive avoidance test , morris water maze test and biochemical indicators detection were performed .Results In step‐down passive avoidance test ,the latent period in model group was significantly shortened(P<0 .05) ,the fault frequency was increased when compared with control group (P<0 .05) .During the Morris Water Maze test ,the latent period for seeking escape from platform in AD mice were obviously ex‐tended(P<0 .05) ,the times of passing through the platform was shortened(P<0 .05) ,the swimming path length around the escape from platform ,swimming time and distance in the effective area in AD mice were increased(P<0 .05) ,meanwhile the level of MDA in brain tissue was significantly increased ,while the levels of Ach and SOD were significantly decreased(P<0 .05) .These indicators in middle and high dose of Naofuzhi group obviously improved .Conclusion Naofuzhi has the multi‐target prevention and treatment effect on AD .
2.Risk factors and outcome of symptomatic basal artery atherosclerotic stenosis
Jiang ZHANG ; Jiannan WU ; Yanbo PENG ; Lisha CHANG ; Dali WANG ; Li ZHANG ; Jingyue WANG ; Min LI ; Xin XIONG ; Jian LIU ; Dan LI
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2018;20(2):175-178
Objective To study the risk factors and outcome of symptomatic BAAS.Methods Eighty symptomatic BAAS patients served as a BAAS group and 80 symptomatic anterior circulation stroke (ACS) patients served as a ACS group in this study.The risk factors for symptomatic BAAS were compared.The symptomatic BAAS patients were further divided into mild-moderate stenosis group (n =43) and severe stenosis group (n=37),progressive stenosis group (n =34) and non-gressive group (n=46),survival group (n=42) and death group (n=38) respectively.The relationship between risk factors and outcome of symptomatic BAAS was analyzed.Results The rate of male patients and the incidence of hypertention were significantly higher in BAAS group than in ACS group (75.0% vs 57.5%,80.0% vs 66.3%,P<0.01).The history of ischemic stroke and smoking was related with the severity of BAAS (P<0.05).Premonitory symptoms were re lated with the progression of BAAS (P<0.01).Pulmonary infection and tracheal intubation or tracheotomy were related with the outcome of BAAS (P<0.01).Conclusion Male gender,hypertension,and history of ischemic stroke and smoking are the independent risk factors for symptomatic BAAS which is less likely to progress in patients with premonitory symptoms.Pulmonary infection and tracheal intubation or tracheotomy are the independent risk factors.